BioNTech SE (BNTX) Share-based Compensation (2019 - 2025)

BioNTech SE (BNTX) has 7 years of Share-based Compensation data on file, last reported at $28.1 million in Q4 2025.

• In Q4 2025, Share-based Compensation rose 11.71% year-over-year to $28.1 million; the TTM figure through Dec 2025 stood at $120.3 million (up 9.83% YoY), while the FY2025 annual figure was $120.0 million, up 11.28% from the prior year.
• Share-based Compensation slipped to $28.1 million in Q4 2025, from $32.6 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $73.6 million in Q3 2021 and bottomed at $20.87 in Q1 2021.
• A 5-year average of $26.1 million and a median of $22.9 million in 2022 frame the typical range for Share-based Compensation.
• The widest YoY moves for Share-based Compensation: up 269441191.15% in 2021, down 100.0% in 2021.
• Year by year, Share-based Compensation stood at $23.5 million in 2021, then dropped by 3.42% to $22.6 million in 2022, then sank by 32.54% to $15.3 million in 2023, then surged by 64.36% to $25.1 million in 2024, then increased by 11.71% to $28.1 million in 2025.
• The last three Share-based Compensation figures came in at $28.1 million (Q4 2025), $32.6 million (Q3 2025), and $36.3 million (Q2 2025), per Business Quant data.

Peer Comparison